Expanding the Horizons Of Proton Beam Therapy

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Cancer Letter recently published information regarding proton therapy facilities in the U.S., highlighting a contention that 85 percent of patients treated with protons have prostate cancer, the logical implication of which would be that this important resource is utilized minimally for other cancers. In this response, we wish to correct this erroneous impression and also wish to highlight the direction that this technology is moving in.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Minesh P. Mehta
Professor of radiation oncology, University of Maryland School of Medicine; Medical director, Maryland Proton Treatment Center
Katja Langen
Associate professor of radiation oncology, University of Maryland School of Medicine;
Associate chief of proton physics, Maryland Proton Treatment Center
William F. Regine
Isadore and Fannie Schneider Foxman Chair and Professor of Radiation Oncology, University of Maryland School of Medicine; Executive director, Maryland Proton Treatment Center

YOU MAY BE INTERESTED IN

In this episode of In the Headlines, former NCI Director Kimryn Rathmell speaks with Paul Goldberg, publisher of The Cancer Letter, and Jacquelyn Cobb, associate editor, about the HHS layoffs and their potential impact on mental health. These layoffs—and the broader uncertainty introduced by the current administration’s actions—are a form of trauma, Rathmell says.
Earlier this week, Robert F. Kennedy Jr. was confirmed as secretary of Health and Human Services amid many resignations at federal health agencies and cancellations of NIH and NCAB meetings. All of this happened at a time when the Trump administration is reportedly preparing to fire thousands of HHS workers.
Minesh P. Mehta
Professor of radiation oncology, University of Maryland School of Medicine; Medical director, Maryland Proton Treatment Center
Katja Langen
Associate professor of radiation oncology, University of Maryland School of Medicine;
Associate chief of proton physics, Maryland Proton Treatment Center
William F. Regine
Isadore and Fannie Schneider Foxman Chair and Professor of Radiation Oncology, University of Maryland School of Medicine; Executive director, Maryland Proton Treatment Center

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login